322 related articles for article (PubMed ID: 19508712)
1. Web-based guided insulin self-titration in patients with type 2 diabetes: the Di@log study. Design of a cluster randomised controlled trial [TC1316].
Roek MG; Welschen LM; Kostense PJ; Dekker JM; Snoek FJ; Nijpels G
BMC Fam Pract; 2009 Jun; 10():40. PubMed ID: 19508712
[TBL] [Abstract][Full Text] [Related]
2. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
[TBL] [Abstract][Full Text] [Related]
3. Does a patient-managed insulin intensification strategy with insulin glargine and insulin glulisine provide similar glycemic control as a physician-managed strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study: a randomized noninferiority trial.
Harris SB; Yale JF; Berard L; Stewart J; Abbaszadeh B; Webster-Bogaert S; Gerstein HC
Diabetes Care; 2014; 37(3):604-10. PubMed ID: 24170757
[TBL] [Abstract][Full Text] [Related]
4. HeLP-Diabetes: randomised controlled trial protocol.
Murray E; Dack C; Barnard M; Farmer A; Li J; Michie S; Pal K; Parrott S; Ross J; Sweeting M; Wood B; Yardley L
BMC Health Serv Res; 2015 Dec; 15():578. PubMed ID: 26715038
[TBL] [Abstract][Full Text] [Related]
5. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
Spirk D; Lareida J; Scheidegger K; Diem P
Praxis (Bern 1994); 2009 Mar; 98(6):315-20. PubMed ID: 19291638
[TBL] [Abstract][Full Text] [Related]
6. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
[TBL] [Abstract][Full Text] [Related]
7. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.
Bretzel RG; Nuber U; Landgraf W; Owens DR; Bradley C; Linn T
Lancet; 2008 Mar; 371(9618):1073-84. PubMed ID: 18374840
[TBL] [Abstract][Full Text] [Related]
8. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
9. Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS).
ATLAS Study Group
Diabetes Technol Ther; 2011 Jan; 13(1):67-72. PubMed ID: 21175274
[TBL] [Abstract][Full Text] [Related]
10. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
Jacober SJ; Scism-Bacon JL; Zagar AJ
Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
[TBL] [Abstract][Full Text] [Related]
12. Web-based collaborative care for type 1 diabetes: a pilot randomized trial.
McCarrier KP; Ralston JD; Hirsch IB; Lewis G; Martin DP; Zimmerman FJ; Goldberg HI
Diabetes Technol Ther; 2009 Apr; 11(4):211-7. PubMed ID: 19344195
[TBL] [Abstract][Full Text] [Related]
13. Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care.
Khunti K; Davies MJ; Kalra S
Diabetes Obes Metab; 2013 Aug; 15(8):690-700. PubMed ID: 23253563
[TBL] [Abstract][Full Text] [Related]
14. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
Davies M; Evans R; Storms F; Gomis R; Khunti K
Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
[TBL] [Abstract][Full Text] [Related]
15. Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial.
Zinman B; Fulcher G; Rao PV; Thomas N; Endahl LA; Johansen T; Lindh R; Lewin A; Rosenstock J; Pinget M; Mathieu C
Lancet; 2011 Mar; 377(9769):924-31. PubMed ID: 21396703
[TBL] [Abstract][Full Text] [Related]
16. Diabetes patients' experiences with the implementation of insulin therapy and their perceptions of computer-assisted self-management systems for insulin therapy.
Simon AC; Gude WT; Holleman F; Hoekstra JB; Peek N
J Med Internet Res; 2014 Oct; 16(10):e235. PubMed ID: 25340869
[TBL] [Abstract][Full Text] [Related]
17. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
[TBL] [Abstract][Full Text] [Related]
18. Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
Lundby Christensen L; Almdal T; Boesgaard T; Breum L; Dunn E; Gade-Rasmussen B; Gluud C; Hedetoft C; Jarloev A; Jensen T; Krarup T; Johansen LB; Lund SS; Madsbad S; Mathiesen E; Moelvig J; Nielsen F; Perrild H; Pedersen O; Roeder M; Sneppen SB; Snorgaard O; Tarnow L; Thorsteinsson B; Vaag A; Vestergaard H; Wetterslev J; Wiinberg N;
Diabetes Obes Metab; 2009 Apr; 11(4):315-22. PubMed ID: 19267709
[TBL] [Abstract][Full Text] [Related]
19. Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: the ATLANTIC study.
Mathieu C; Storms F; Tits J; Veneman TF; Colin IM
Acta Clin Belg; 2013; 68(1):28-33. PubMed ID: 23627191
[TBL] [Abstract][Full Text] [Related]
20. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
